Brief: Germany's Evotec Gets Takeover Interest From Halozyme At About 11 Euros Per Share - Bloomberg News
Nov 14 (Reuters) -
* GERMANY'S EVOTEC GETS TAKEOVER INTEREST FROM HALOZYME AT
ABOUT
€11 PER SHARE - BLOOMBERG NEWS
Source text: https://tinyurl.com/2veteceh
Further company coverage: EVTG.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases